These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10476790)

  • 1. Risk factors for late presentation in chronic glaucoma.
    Fraser S; Bunce C; Wormald R
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2251-7. PubMed ID: 10476790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective analysis of risk factors for late presentation of chronic glaucoma.
    Fraser S; Bunce C; Wormald R
    Br J Ophthalmol; 1999 Jan; 83(1):24-8. PubMed ID: 10209429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for first presentation of glaucoma with significant visual field loss.
    Deva NC; Insull E; Gamble G; Danesh-Meyer HV
    Clin Exp Ophthalmol; 2008 Apr; 36(3):217-21. PubMed ID: 18412589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cases of advanced visual field loss at referral to glaucoma clinics - more men than women?
    Crabb DP; Saunders LJ; Edwards LA
    Ophthalmic Physiol Opt; 2017 Jan; 37(1):82-87. PubMed ID: 27862125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprivation and late presentation of glaucoma: case-control study.
    Fraser S; Bunce C; Wormald R; Brunner E
    BMJ; 2001 Mar; 322(7287):639-43. PubMed ID: 11250847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The analysis of various extent visual field defect in chronic glaucoma patients].
    Zhong Y; Ye W; Luo X
    Yan Ke Xue Bao; 2004 Dec; 20(4):213-8. PubMed ID: 15656362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study.
    Czudowska MA; Ramdas WD; Wolfs RC; Hofman A; De Jong PT; Vingerling JR; Jansonius NM
    Ophthalmology; 2010 Sep; 117(9):1705-12. PubMed ID: 20591487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating patients presenting with advanced glaucoma--should we reconsider current practice?
    King AJ; Stead RE; Rotchford AP
    Br J Ophthalmol; 2011 Sep; 95(9):1185-92. PubMed ID: 21097788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.
    Boodhna T; Crabb DP
    Ophthalmic Physiol Opt; 2015 Mar; 35(2):225-30. PubMed ID: 25545852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J;
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic glaucoma: a preventable cause of blindness.
    Crick RP
    Lancet; 1974 Feb; 1(7850):205-7. PubMed ID: 4129886
    [No Abstract]   [Full Text] [Related]  

  • 12. Glaucoma care and clinical profile in Priest Hospital, Thailand.
    Sothornwit N; Jenchitr W; Pongprayoon C
    J Med Assoc Thai; 2008; 91 Suppl 1():S111-8. PubMed ID: 18672602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of glaucoma types and legal blindness from glaucoma in the western region of Saudi Arabia: a hospital-based study.
    Eid TM; el-Hawary I; el-Menawy W
    Int Ophthalmol; 2009 Dec; 29(6):477-83. PubMed ID: 18853106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glaucomatous damage in normotensive fellow eyes of patients with unilateral hypertensive pseudoexfoliation glaucoma: normotensive pseudoexfoliation glaucoma?
    Yarangümeli A; Davutluoglu B; Köz OG; Elhan AH; Yaylaci M; Kural G
    Clin Exp Ophthalmol; 2006; 34(1):15-9. PubMed ID: 16451253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for visual field progression in treated glaucoma.
    De Moraes CG; Juthani VJ; Liebmann JM; Teng CC; Tello C; Susanna R; Ritch R
    Arch Ophthalmol; 2011 May; 129(5):562-8. PubMed ID: 21555607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency doubling technology perimetry abnormalities as predictors of glaucomatous visual field loss.
    Medeiros FA; Sample PA; Weinreb RN
    Am J Ophthalmol; 2004 May; 137(5):863-71. PubMed ID: 15126151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania.
    Jones PR; Philippin H; Makupa WU; Burton MJ; Crabb DP
    Ophthalmic Epidemiol; 2020 Feb; 27(1):10-18. PubMed ID: 31517561
    [No Abstract]   [Full Text] [Related]  

  • 19. The 12-year incidence of glaucoma and glaucoma-related visual field loss in Italy: the Ponza eye study.
    Cedrone C; Mancino R; Ricci F; Cerulli A; Culasso F; Nucci C
    J Glaucoma; 2012 Jan; 21(1):1-6. PubMed ID: 21173704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
    Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL
    Ophthalmology; 2003 Aug; 110(8):1484-90. PubMed ID: 12917161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.